Anabolic agents and gene expression around the bone implant interface.
Virdi
A S
AS
Department of Anatomy and Cell Biology, Rush Medical College, Rush University Medical Center,Chicago, IL 60126, USA. amarjit_virdi@rush.edu
De Ranieri
A
A
Kuroda
S
S
Dai
Y
Y
Sumner
D R
DR
D045930:Anabolic Agents / Q000378:metabolism / Q000494:pharmacology*; D000818:Animals; D016465:Bone Marrow Purging; D001861:Bone Regeneration / Q000187:drug effects / Q000235:genetics*; D016025:Bone Transplantation / Q000379:methods / Q000502:physiology; D001842:Bone and Bones / Q000187:drug effects / Q000378:metabolism; D004195:Disease Models, Animal; D004305:Dose-Response Relationship, Drug; D015536:Down-Regulation / Q000187:drug effects / Q000235:genetics; D016326:Extracellular Matrix Proteins / Q000187:drug effects / Q000235:genetics; D020869:Gene Expression Profiling; D005786:Gene Expression Regulation / Q000187:drug effects / Q000502:physiology*; D006085:Graft Survival / Q000187:drug effects / Q000235:genetics*; D006133:Growth Substances / Q000235:genetics; D010012:Osteogenesis / Q000187:drug effects / Q000235:genetics*; D051381:Rats; D013997:Time Factors; D016212:Transforming Growth Factor beta / Q000378:metabolism / Q000494:pharmacology*; D053781:Transforming Growth Factor beta2; D015854:Up-Regulation / Q000187:drug effects / Q000235:genetics
D045930:Anabolic Agents; D016326:Extracellular Matrix Proteins; D006133:Growth Substances; D016212:Transforming Growth Factor beta; D053781:Transforming Growth Factor beta2